First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2015-02-12 22:31:24Open Document File Size: 3,40 MBShare Result on FacebookCityMEAN CHANGE / /CompanyLate 2013 Chengdu Kanghong Pharmaceutical group / ALLERGAN / AMD / /CountryAustralia / /CurrencyAMD / /EventFDA Phase / Product Issues / /Facilitystore CNTF / BEACON Sponsor / Stable BCVA / /MedicalConditionoxidative stress Disease / HIV / disease / insignificant disease / phototoxicity / Macular Degeneration / Optic nerve injury / inflammation / blindness / asthma / /MedicalTreatmentGene therapy / laser therapy / Stem Cell therapy / dietary supplements / radiotherapy / drug delivery systems / Radiation / /OrganizationRegional Congress / FDA / /PersonAmy Cohn / /ProductFluocinolone acetonide / Avastin / Lucentis / oxygen / FOVISTA / Patients Fovista™ / nutrient delivery / /PublishedMediumBaseline / /TechnologyGene therapy / Radiation / Laser / drug delivery / Cell therapy / drug delivery technology / Drug Delivery System / apoptosis / /SocialTag |